ALT is more liver-specific than AST and is the primary marker for hepatocellular damage. Elevated ALT on oral AAS is a direct signal of hepatic stress and requires dose reduction or cycle termination if values exceed 3× upper limit of normal.
ALT above 168 U/L (3× ULN) on oral AAS is a clinical threshold for discontinuation; persistent elevation risks cholestasis, peliosis hepatis, and in severe cases hepatocellular carcinoma with long-term use.
Upload your bloodwork and get a full analysis of your ALT (SGPT) in context with your complete panel — including TRT-specific reference ranges and personalized insights.
Analyze My Bloodwork →GearCheck provides blood marker analysis and harm reduction education. Information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional.